Company profile for Applied Molecular Transport

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Applied Molecular Therapeutics is committed to developing novel, oral biological therapeutics to treat severe autoimmune, metabolic and inflammatory diseases. To achieve this, the company is leveraging its propriety technology platform to create oral therapeutics that harness naturally occurring transport and targeting mechanisms to cross the protective barrier of the intestinal epithelium (IE). Once across the IE, the therape...
Applied Molecular Therapeutics is committed to developing novel, oral biological therapeutics to treat severe autoimmune, metabolic and inflammatory diseases. To achieve this, the company is leveraging its propriety technology platform to create oral therapeutics that harness naturally occurring transport and targeting mechanisms to cross the protective barrier of the intestinal epithelium (IE). Once across the IE, the therapeutics gain privileged access to the immune system, creating the potential for therapeutics payloads to act directly at the point of origin of immune dysregulation and restore immune homeostasis.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1 Tower Place Suite 850 South San Francisco, CA 94080
Telephone
Telephone
+1 650.392.0420
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20231227151063/en

BUSINESSWIRE
27 Dec 2023

https://www.globenewswire.com//news-release/2023/11/09/2777778/0/en/Applied-Molecular-Transport-Reports-Third-Quarter-2023-Financial-Results.html

GLOBENEWSWIRE
09 Nov 2023

https://www.businesswire.com/news/home/20230921110888/en

BUSINESSWIRE
21 Sep 2023

https://www.globenewswire.com/news-release/2023/08/14/2724950/0/en/Applied-Molecular-Transport-Reports-Second-Quarter-2023-Financial-Results.html

GLOBENEWSWIRE
14 Aug 2023

https://www.globenewswire.com/news-release/2023/05/11/2667310/0/en/Applied-Molecular-Transport-Reports-First-Quarter-2023-Financial-Results.html

GLOBENEWSWIRE
11 May 2023
AMT lays off further 57% of staff, seeks strategic alternatives
AMT lays off further 57% of staff, seeks strategic alternatives

28 Mar 2023

// James Waldron FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/amt-lays-further-57-employees-seeks-out-strategic-alternatives

James Waldron FIERCE BIOTECH
28 Mar 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty